Khalil Hajiasgharzadeh

13PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 04, 2025
An Updated Review on Dysregulated lncRNAs and their Contribution to the Various Molecular Types of Lung Carcinoma.

Narges Dastmalchi, Mohammad Reza Alipour, Reza Safaralizadeh

|Jun 10, 2022
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.

Bita Amir Taghavi, Nazila Alizadeh, Hossein Saeedi

|Nov 10, 2020
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki

|Sep 28, 2020
COVID-19 Infection: Concise Review Based on the Immunological Perspective.

Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary

|Aug 27, 2020
Recent developments of RNA-based vaccines in cancer immunotherapy.

Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri

|Jul 16, 2020
Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification.

Zeynab Aaliyari-Serej, Ayyub Ebrahimi, Balal Barazvan

Pageof 3

Frequent Collaborators

12 joint publications

Behzad Baradaran

4 joint publications

Behzad Mansoori

4 joint publications

Ahad Mokhtarzadeh

4 joint publications

Afshin Derakhshani